5 Oversold Blue Chip Stocks To Buy

4. HCA Healthcare, Inc. (NYSE:HCA)

Number of Hedge Fund Holders: 65

14-day RSI as of August 3: 26.72

A.J. Rice at Credit Suisse holds an Outperform rating on HCA Healthcare, Inc. (NYSE:HCA) shares, alongside a $316 price target, as of July 28.

HCA Healthcare, Inc. (NYSE:HCA) provides healthcare services in the US. It is based in Nashville, Tennessee.

A total of 65 hedge funds were long HCA Healthcare, Inc. (NYSE:HCA) in the first quarter, with a total stake value of $2.8 billion.

Baron Funds mentioned HCA Healthcare, Inc. (NYSE:HCA) in its second-quarter 2023 investor letter:

“The flip side of higher medical utilization trends is that health care providers and medical device companies will benefit. We own HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s largest providers of health care services, with 182 hospitals and 2,300 ambulatory sites of care in 20 states and the U.K. We own several medical device companies that should benefit in the short term from procedure recovery and in the long term from new product innovation and increasing demand driven by an aging global population and a higher disease burden from chronic diseases. For the most part, our investments are in companies addressing non-elective procedures, which makes them less likely to be deferred in a recession.”